Agios Pharmaceuticals Inc (AGIO.OQ) Analyst Research| Reuters.com
Edition:
United States

Agios Pharmaceuticals Inc (AGIO.OQ)

AGIO.OQ on NASDAQ Stock Exchange Global Select Market

44.27USD
24 Jun 2016
Change (% chg)

$-4.23 (-8.72%)
Prev Close
$48.50
Open
$45.76
Day's High
$47.13
Day's Low
$44.21
Volume
384,196
Avg. Vol
261,009
52-wk High
$120.81
52-wk Low
$33.51

Reports per page
Select Report Title Date Provider Pgs Price
Agios Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 24 Jun 2016 Reuters Investment Profile 12 20.00
Thomson Reuters Stock Report - Agios Pharmaceuticals Inc (AGIO-O) 24 Jun 2016 Thomson Reuters Stock Report 12 25.00
ValuEngine Rating and Forecast Report for AGIO 18 Jun 2016 ValuEngine, Inc. 11 25.00
AGIOS PHARMACEUTICALS INC (AGIO=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS 17 Jun 2016 Pechala's Reports 2 25.00
Value Graph: AGIOS PHARMA -- AGIO 16 Jun 2016 Ford Investor Services, Inc. 1 12.00
AGIO.OQ - Event Transcript of Agios Pharmaceuticals Inc conference call, Jun. 12, 2015 / 8:00AM ET 12 Jun 2015 Thomson Reuters StreetEvents 22 75.00
 
Name Age Since Current Position

David Schenkein

57 2013 Chief Executive Officer, Director

Glenn Goddard

44 2013 Senior Vice President - Finance

Scott Biller

59 Chief Scientific Officer

Christopher Bowden

54 2014 Chief Medical Officer

Steven Hoerter

44 2016 Chief Commercial Officer